- Home
- WT vs SPRY Comparison
WT vs SPRY Comparison
Compare WT & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WT
- SPRY
- Stock Information
- Founded
- WT 1985
- SPRY 2015
- Country
- WT United States
- SPRY United States
- Employees
- WT N/A
- SPRY N/A
- Industry
- WT Investment Bankers/Brokers/Service
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- WT Finance
- SPRY Health Care
- Exchange
- WT Nasdaq
- SPRY Nasdaq
- Market Cap
- WT 2.0B
- SPRY 1.8B
- IPO Year
- WT N/A
- SPRY N/A
- Fundamental
- Price
- WT $13.44
- SPRY $10.07
- Analyst Decision
- WT Buy
- SPRY Strong Buy
- Analyst Count
- WT 5
- SPRY 5
- Target Price
- WT $12.78
- SPRY $31.00
- AVG Volume (30 Days)
- WT 4.3M
- SPRY 3.0M
- Earning Date
- WT 10-24-2025
- SPRY 08-13-2025
- Dividend Yield
- WT 0.89%
- SPRY N/A
- EPS Growth
- WT N/A
- SPRY N/A
- EPS
- WT 0.40
- SPRY N/A
- Revenue
- WT $444,568,000.00
- SPRY $112,339,000.00
- Revenue This Year
- WT $12.04
- SPRY N/A
- Revenue Next Year
- WT $9.42
- SPRY $182.40
- P/E Ratio
- WT $33.19
- SPRY N/A
- Revenue Growth
- WT 15.43
- SPRY 22367.80
- 52 Week Low
- WT $7.47
- SPRY $9.97
- 52 Week High
- WT $14.07
- SPRY $18.90
- Technical
- Relative Strength Index (RSI)
- WT 54.09
- SPRY 20.04
- Support Level
- WT $13.27
- SPRY $10.98
- Resistance Level
- WT $13.72
- SPRY $14.00
- Average True Range (ATR)
- WT 0.34
- SPRY 0.80
- MACD
- WT -0.02
- SPRY -0.36
- Stochastic Oscillator
- WT 49.64
- SPRY 1.95
About WT WisdomTree Inc.
WisdomTree Inc is a financial innovator, offering a well-diversified suite of exchange-traded products (ETPs), models and solutions. It offers a broad range of ETFs and exchange-traded products (ETPs). The firm also engages in developing next-generation digital products and structures, including digital funds and tokenized assets, as well as its blockchain-native digital wallet, WisdomTree Prime. The Company conducts business under a single operating segment as an ETP sponsor and asset manager.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.